Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report

BACKGROUND: The treatment of advanced or metastatic renal cell carcinoma (RCC) has drastically changed since the approval of immune checkpoint therapy. Nivolumab is a treatment option for patients with metastatic RCC, previously treated with targeted antiangiogenic therapy. The efficacy of nivolumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguchi, Go, Tsutsumi, Sohgo, Yasui, Masato, Ohtake, Shinji, Umemoto, Susumu, Nakaigawa, Noboru, Yao, Masahiro, Kishida, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907256/
https://www.ncbi.nlm.nih.gov/pubmed/29669553
http://dx.doi.org/10.1186/s12894-018-0339-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907256/
https://www.ncbi.nlm.nih.gov/pubmed/29669553
http://dx.doi.org/10.1186/s12894-018-0339-2

Ejemplares similares